Markets & Stocks

Stock quotes, market indicators and the latest market news.

Market Summary Market News Stock Quotes Market Movers
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

8.155 +0.195 (+2.45%)
Delayed Quote Updated: 1:55 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
US Stock Market Movers: Top Gainers and Losers for the Session ↗
Via Chartmill
News headline image
Bausch Health (BHC) Q3 2026 Earnings Call Transcript ↗
CEO highlights $1B EBITDA milestone and $521M debt reduction. 
Via The Motley Fool
Topics Earnings
News headline image
What Bausch Health Cos (BHC) Said on Its Q3 Earnings Call ↗
Bausch Health Cos (NYSE:BHC) raised its full-year 2026 outlook for the second consecutive quarter after reporting third-quarter growth across its operating segments, led by Salix and supported by... 
Via MarketBeat
Topics Earnings Initial Public Offering
BHC Stock Plummets On Failed Liver Cirrhosis Trial: Retail Says ‘Lost Battle But Not The War’ ↗
Via Stocktwits
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 30, 2025 ↗
 
Via Benzinga
News headline image
Bausch Health Companies's Earnings Outlook ↗
 
Via Benzinga
After-Hours Movers: LABT, NCPL Top Gainers; Fortinet, AUROW Top Losers ↗
Via Chartmill
News headline image
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month ↗
Much of this was due to a very well-received quarterly earnings report. 
Via The Motley Fool
News headline image
Bausch Health (BHC) Q2 2026 Earnings Call Transcript ↗
Xifaxan surged 26% and Solta margins expanded sharply on strong growth. 
Via The Motley Fool
Topics Earnings
News headline image
Bausch Health Cos Q2 Earnings Call Highlights ↗
Bausch Health Cos (NYSE:BHC) reported second-quarter results that management said extended its streak of revenue and adjusted EBITDA growth to 13 consecutive quarters, driven by performance in its... 
Via MarketBeat
Topics Earnings
News headline image
Why Bausch Health Companies Was Crawling Higher This Week ↗
Investors liked what they saw with the company's opening 2026 earnings report. 
Via The Motley Fool
News headline image
Bausch Health (BHC) Q1 2026 Earnings Transcript ↗
Bausch Health (BHC) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Bausch Health (BHC) Q3 2024 Earnings Transcript ↗
Bausch Health (BHC) Q3 2024 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
News headline image
Bausch Health (BHC) Q4 2025 Earnings Transcript ↗
Bausch Health (BHC) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention ↗
Bausch Health's turnaround could pay off for value investors patient enough to wait for it. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake ↗
Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence. 
Via The Motley Fool
News headline image
Why Bausch Health Companies Stock Rocketed 11% Higher Today ↗
Investors were obviously impressed with the company's latest acquisition. 
Via The Motley Fool
Biggest Stock Movers Today, Dec. 1: BHC, SMR, & More ↗
Markets gave up ground to start the new month. 
Via The Motley Fool
Topics Stocks
News headline image
Hedge Fund Billionaire Carl Icahn's Q3: The Activist Goes Defensive, Dumps A Disaster, And Loads Up On EchoStar ↗
Carl Icahn's hedge fund Q3 portfolio reshuffle: $9.14B, concentrated, contrarian. Walked away from Bausch Health, added EchoStar. 
Via Benzinga
News headline image
Carl Icahn's Biggest Bet Just Torched Half His Fortune ↗
Carl Icahn's empire, IEP, has collapsed 80% due to Hindenburg's short-selling attack. Icahn's net worth is down 75%. 
Via Benzinga
News headline image
Bausch Health (BHC) Q3 2025 Earnings Transcript ↗
Bausch Health (BHC) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Insiders Signal Caution: A Deep Dive into Recent Trading Trends and Market Implications
Corporate insiders, often privy to the most granular details of their companies' health and future prospects, have been sending a clear signal to the market over the past 12-18 months: caution. A... 
Via MarketMinute
Topics Artificial Intelligence Economy Regulatory Compliance
News headline image
Retail Investors' Top Stocks With Earnings This Week: SoFi, Apple, Meta And More ↗
Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites. 
Via Benzinga
News headline image
A Look Into Bausch Health Companies Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Billionaire Investor Buys Google And This Gold Miner Stock ↗
John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet. 
Via Benzinga
News headline image
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited ↗
Carl Icahn's 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names like CTRI and IFF. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout ↗
Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.